Appetite stimulants

Medical Marijuana, Inc. Subsidiary HempMeds® Announces Import Permits for First-Ever THC-Free CBD Product in Argentina

Retrieved on: 
Wednesday, June 13, 2018

Argentina's National Administration of Medicines, Food and Medical Technology (ANMAT) has approved the product for import.

Key Points: 
  • Argentina's National Administration of Medicines, Food and Medical Technology (ANMAT) has approved the product for import.
  • "As a company of firsts, we're proud to offer the first THC-free CBD product in Argentina," said Medical Marijuana, Inc. CEO Dr. Stuart Titus.
  • "We're very excited to partner with HempMeds and distribute these high-quality CBD products in our country," said FLOS Innovation CEO Carlos Mendez.
  • In Argentina, CBD products are sold for compassionate use and must be prescribed by a licensed physician.

Panacea Life Sciences Launches Vet-Grade Hemp Oil Tablets for the Equine Industry

Retrieved on: 
Wednesday, June 13, 2018

LOUISVILLE, Colo., June 13, 2018 /PRNewswire/ -- Panacea Life Sciences, located outside of Boulder, CO, expands their human and pet hemp oil products line with the launch of Panacea Equine now available for veterinarians, horse owners and those in the performance horse industry.

Key Points: 
  • LOUISVILLE, Colo., June 13, 2018 /PRNewswire/ -- Panacea Life Sciences, located outside of Boulder, CO, expands their human and pet hemp oil products line with the launch of Panacea Equine now available for veterinarians, horse owners and those in the performance horse industry.
  • "Extracted from industrial hemp plants, the phytocannabinoids in Panacea Equine provide potent anti-inflammatory and analgesic properties to help horses recover from exercise-induced joint damage and alleviate the symptoms of osteoarthritis."
  • Provided as a chewable hemp oil tablet, Panacea Equine offers horse owners and those in the horse industry an all-natural, non-invasive treatment method.
  • Unlike other hemp oil products available, Panacea products contain zero THC, the psychoactive compound found in the cannabis plant.

Zoned Properties to Participate in Panel Discussion at The Green Zone: Coachella Valley Industry Event

Retrieved on: 
Tuesday, June 12, 2018

The panel, entitled "Real Estate Investor, Developer and Owner Perspectives on Cannabis-related Properties," will include a discussion of price premiums for cannabis real estate, business models for cannabis growers, rehabilitation vs. new build scenarios, zoning challenges and emerging deal structures.

Key Points: 
  • The panel, entitled "Real Estate Investor, Developer and Owner Perspectives on Cannabis-related Properties," will include a discussion of price premiums for cannabis real estate, business models for cannabis growers, rehabilitation vs. new build scenarios, zoning challenges and emerging deal structures.
  • Zoned Properties is an accredited member of the Better Business Bureau, the Forbes Real Estate Council, and the U.S. Green Building Council.
  • Zoned Properties targets commercial properties that can be acquired and re-zoned or permitted for specific purposes.
  • Zoned Properties does not grow, harvest, sell or distribute cannabis or any substances regulated under United States law such as the Controlled Substances Act.

Therapix Biosciences Sponsors the 2018 Annual Meeting of the European Society for the Study of Tourette Syndrome

Retrieved on: 
Monday, June 11, 2018

Dr. Bloch, an Associate Professor at the Yale University Child Study Center, the investigator-initiator of the trial, and a member of the Company's scientific advisory board committee.

Key Points: 
  • Dr. Bloch, an Associate Professor at the Yale University Child Study Center, the investigator-initiator of the trial, and a member of the Company's scientific advisory board committee.
  • The study, suggesting that the proprietary cannabinoid combination THX-110 [which is a combination of dronabinol (-9-tetrahydracannabinol) and palmitoylethanolamide (PEA)] showed significantly improved symptoms over time in adult subjects with Tourette syndrome ( link to press release ).
  • The study was led together with James F. Leckman, M.D., Ph.D., of the Neison Harris Professor in the Child Study Center and Professor of Pediatrics Child Psychiatry at Yale University.
  • Therapix Biosciences Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of Senior Executives and Scientists.

MMJ International Holdings New FDA Multiple Sclerosis Study Pushes Cannabis Components Closer To FDA Approval

Retrieved on: 
Monday, June 11, 2018

Dr. Bianca Weinstock-Guttmanis a Professor of Neurology at the State University of New York at Buffalo who serves as Executive Director of the New York State Multiple Sclerosis Consortium will execute the FDA approved study exploring the potential therapeutic applications of cannabinoids for progressive multiple sclerosis patients.

Key Points: 
  • Dr. Bianca Weinstock-Guttmanis a Professor of Neurology at the State University of New York at Buffalo who serves as Executive Director of the New York State Multiple Sclerosis Consortium will execute the FDA approved study exploring the potential therapeutic applications of cannabinoids for progressive multiple sclerosis patients.
  • MMJ BioScience's will be providing new evidence regarding clinical outcomes leading to commercial success in the scientific process of MMJ BioScience's first pharmaceutical (THC) cannabidiol (CBD) derived medicine.
  • MMJ will soon commence their Phase 2 clinical trials with the guidance of their clinical research organization.
  • The FDA will assess our new drug application (NDA) based only on our scientific data, irrespective of the drug being sourced from natural botanical materials."

Kush Bottles, Inc. Prices $36,000,000 Registered Direct Offering

Retrieved on: 
Friday, June 8, 2018

The gross proceeds of the offering will be approximately $36,000,000 before deducting placement agent fees and other estimated offering expenses.

Key Points: 
  • The gross proceeds of the offering will be approximately $36,000,000 before deducting placement agent fees and other estimated offering expenses.
  • The closing of the registered direct offering is expected to take place on or about June 12, 2018, subject to the satisfaction of customary closing conditions.
  • This offering is being made pursuant to an effective shelf registration statement on Form S-3 (File No.
  • Kush Bottles has no direct involvement with the cannabis plant or any products that contain tetrahydrocannabinol (commonly referred to as THC) or CBD.

Dr. Michele Ross, Leading Cannabis Voice, Joins NanoSphere Health Sciences Team

Retrieved on: 
Thursday, June 7, 2018

NanoSphere Delivery System represents one of the most important developments for advancing the non-invasive and user-friendly delivery of biological agents in over 25 years.

Key Points: 
  • NanoSphere Delivery System represents one of the most important developments for advancing the non-invasive and user-friendly delivery of biological agents in over 25 years.
  • Evolve's pioneering product, Transdermal NanoSerum, is a fast-acting, ultra-strength transdermal formula infused with nano-encapsulated cannabis and cannabis extracts.
  • Evolve Formula products leverage NanoSphere Health Sciences patented NanoSphere Delivery System.
  • The NanoSphere Delivery System is a revolutionary platform using nanotechnology in the biodelivery of supplements, nutraceuticals and over-the-counter medications for the cannabis, pharmaceutical and animal health industries, and beyond.

Data shows Investments in Cannabis Market Continues to Accelerate

Retrieved on: 
Monday, June 4, 2018

This reflects the necessity to scale cannabis businesses, to get some kind of advantage, and to explore strategic opportunities, both through acquisitions and international expansion."

Key Points: 
  • This reflects the necessity to scale cannabis businesses, to get some kind of advantage, and to explore strategic opportunities, both through acquisitions and international expansion."
  • Members of the committee, including many prestigious doctors, professors and researchers, will discuss and review the entire cannabis plant, cannabis resin, extracts and tinctures of cannabis, Delta-9-tetrahydrocannabidiol (THC) and isomers of THC.
  • Terra Tech received State of California Temporary Authorization to cultivate, manufacture, distribute and retail cannabis to the adult-use market, following California's legalization of adult-use cannabis sales effective January 1, 2018.
  • Hiku Brands Company Ltd. (OTC: DJACF) is focused on building a portfolio of engaging cannabis brands, unsurpassed retail experiences and handcrafted cannabis production.

Lannett Receives FDA Approval For Dronabinol Capsules

Retrieved on: 
Monday, May 21, 2018

PHILADELPHIA, May 21, 2018 /PRNewswire/ --Lannett Company, Inc. (NYSE: LCI) today announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Dronabinol Capsules USP, 2.5 mg, 5 mg and 10 mg, the therapeutic equivalent to the reference listed drug, Marinol Capsules 2.5 mg, 5 mg and 10 mg of AbbVie Inc. For the 12 months ended March 2018, total U.S. sales of Dronabinol Capsules USP, 2.5 mg, 5 mg and 10 mg, was approximately $120 million, according to IMS.

Key Points: 
  • PHILADELPHIA, May 21, 2018 /PRNewswire/ --Lannett Company, Inc. (NYSE: LCI) today announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Dronabinol Capsules USP, 2.5 mg, 5 mg and 10 mg, the therapeutic equivalent to the reference listed drug, Marinol Capsules 2.5 mg, 5 mg and 10 mg of AbbVie Inc. For the 12 months ended March 2018, total U.S. sales of Dronabinol Capsules USP, 2.5 mg, 5 mg and 10 mg, was approximately $120 million, according to IMS.
  • "The approval of Dronabinol Capsules adds to our sizeable portfolio of near-term product opportunities," said Tim Crew, chief executive officer of Lannett.
  • "We expect to commence marketing several products including Dronabinol Capsules over the course of this year.
  • Currently, only a handful of manufacturers supply generic Dronabinol Capsules to the U.S.

Aces Extracts Launches Sensation-Based Cannabis Products for Active Lifestyles

Retrieved on: 
Wednesday, May 2, 2018

"Aces is a California grown company that prides itself on developing specialized cannabis products to fit the active lifestyles of our customers.

Key Points: 
  • "Aces is a California grown company that prides itself on developing specialized cannabis products to fit the active lifestyles of our customers.
  • Aces Extracts exclusive, all-natural cannabis distillate formulas have been developed to deliver precise blends of cannabinoid and terpene compounds to the human endocannabinoid system.
  • Aces Extracts extraction scientist have developed their refining process to deliver high purity distillate that regularly tests above 85% tetrahydrocannabinol, the psychoactive component of cannabis.
  • Aces Extracts products are available at select medical and adult-use dispensaries in California and Nevada.